Hiroshi Seki

Hiroshi Seki

Auto-generated profile, based on publicly available information

Hiroshi Seki

Department of Radiology, Niigata Cancer Center Hospital, 2-15-3 Kawagishi-cho, Chuo-ku, Niigata-shi, Niigata 951-8566, Japan

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2001 in Archives of Oral Biology
Verified
Journal Article
Closed access
HHHidetaka Homma
Hidetaka Homma
TTTetsu Takahashi
Tetsu Takahashi
HSHiroshi Seki
Hiroshi Seki
MOMaki Ohtani
Maki Ohtani
TKToshirou Kondoh
Toshirou Kondoh
MFMasayuki Fukuda
Masayuki Fukuda

1 October 1997 in The Journal of Physical Chemistry A
Verified
Journal Article
Closed access
HSHiroshi Seki
Hiroshi Seki
KOKatuji Okada
Katuji Okada
YIYasuhiro Iimura
Yasuhiro Iimura
MHMikio Hoshino
Mikio Hoshino

10 July 2025 in Biomedical Physics & Engineering Express
Verified
Journal Article
Closed access
MUManami Umezu
Manami Umezu
YKYohan Kondo
Yohan Kondo
SIShota Ichikawa
Shota Ichikawa
YSYuki Sasaki
Yuki Sasaki
KKKoji Kaneko
Koji Kaneko
HSHiroshi Seki
Hiroshi Seki
Predicting the risk of breast cancer recurrence is crucial for guiding therapeutic strategies, including enhanced surveillance and the consideration of additional treatment after surgery. In this study, we developed a deep convolutional neural network (DCNN) model to predict recurrence within six years after surgery using preoperative contrast-enhanced computed tomography (CECT) images, which are widely available and effective for detecting distant metastases. This retrospective study included preoperative CECT images from 133 patients with invasive ductal carcinoma. The images were classified into recurrence and no-recurrence groups using ResNet-101 and DenseNet-201. Classification performance was evaluated using the area under the receiver operating curve (AUC) with leave-one-patient-out cross-validation. At the optimal threshold, the classification accuracies for ResNet-101 and DenseNet-201 were 0.73 and 0.72, respectively. The median (interquartile range) AUC of DenseNet-201 (0.70 [0.69–0.72]) was statistically higher than that of ResNet-101 (0.68 [0.66–0.68]) (p < 0.05). These results suggest the potential of preoperative CECT-based DCNN models to predict breast cancer recurrence without the need for additional invasive procedures.